Elevate Medical Affairs Podcast Channel

On this episode of the Medical Affairs Professional Society podcast series, "Elevate", we're speaking about Health Equity with Ariel Katz, CEO of H1. Today, we'll be addressing what the role of Medical Affairs is in creating health equity, whether Medical Affairs is able to promote health equity in ways it couldn't previously – or if Medical Affairs' evolving role in health equity due more to increased awareness.

Previous podcasts explore best practices for expert engagement, but MAPS Partner Circle member, H1, is in a unique position to notice patterns in the ways organizations struggle or simply fail to engage and support external experts. This episode of the Elevate podcast series details 4 things Field Medical teams can do better.

Working in rare disease offers Medical Affairs professionals the opportunity to engage directly with patient organizations and researchers/HCPs deeply involved in providing new options for patients who lack current treatments. However, working in rare disease also comes with significant challenges. Here MAPS sits down at our 2022 Global Annual Meeting with Catherine Parham, Vice President and Head of Global Medical Affairs at Astellas Gene Therapies to talk about the unique position of Medical Affairs in the rare disease space — and how our work in this area is essential for patient benefit.

MAPS speaks with Tim Mikhelashvili, PharmD, CEO & Co-Founder, Amedea Pharma, Inc. and Riaz Abbas, Learning and Performance Lead, JAPAC Medical, Amgen about innovative approaches to Medical Affairs External Education.

Medical Affairs teams have generally gotten comfortable with the use of Real World Evidence (RWE) to answer questions that might previously have been the subject of clinical trials. Here, we speak with Dr. Ivy Weng, Head of Clinical Development & RWE/HEOR, Komodo Health about the use of RWE in not only reacting to questions but as a proactive piece of Medical Affairs strategy and clinical development. 

Medical Affairs has traditionally provided patient education by ensuring healthcare providers are up to date on the latest treatment, development and disease state information. Here MAPS speaks with Tim Mikhelashvili, CEO & Co-Founder, Amedea Pharma, and Riaz Abbas, Learning and Performance Lead, JAPAC Medical, Amgen, about innovative approaches to compliant patient education including communications with patient associations, the use of peer navigators, and the emerging use of social media.

With a million records added annually to PubMed it's easy to get overwhelmed with new research. Not to mention the difficulty of evaluating the quality of research in smaller journals, not to mention preprints and emerging formats like indexed webinars. In this podcast, we speak with Tiago Barros, Managing Director of Faculty Opinions about the need for content curation to cut through the noise — and eventually provide patient benefit. 

In this episode of the Elevate podcast channel, Opening Doors series, MAPS speaks with Renu Juneja, who started a medical writing fellowship program at Janssen, and with two of her former fellowship participants, Jennifer Lee and Lauren Brown. We hope you enjoy this look at one way to find a first position in the pharmaceutical industry! 

In the midst of the COVID-19 pandemic, an informal cross-industry collaboration developed to share information and best-practices as they chartered into the unfamiliar territories of Emergency Use Authorization (EUA), the process, planning and preparation of the MI teams during a global pandemic. This podcast will discuss the how and why this group of MI professionals, who are part of phactMI, a nonprofit collaboration of Medical Information leaders, came together and the lessons learned from their collaboration.  Objectives: The objectives for this podcast series are: Describe the motivation of the companies to participate in a collaboration. List the reasons for the collaboration to form. Identify the goals for the collaboration. Discuss the impact the conversations in the group had on your workstream and with your internal business stakeholders Identify the major lessons learned through the collaboration Discuss how these lessons can be applied in the future 

In the midst of the COVID-19 pandemic, an informal cross-industry collaboration developed to share information and best-practices as they chartered into the unfamiliar territories of Emergency Use Authorization (EUA), the process, planning and preparation of the MI teams during a global pandemic. This podcast, a continuation from Episode 1, will discuss the What of the collaboration– the specific topics covered by phactMI, a nonprofit collaboration of Medical Information leaders. Objectives: The objectives for this podcast series are: Discuss the impact the conversations in the group had on your workstream and with your internal business stakeholders Identify the major lessons learned through the collaboration Discuss how these lessons can be applied in the future 

Attached to every clinical trial is a line of hope for a patient seeking a cure or better way to live with a rare, chronic, or limiting condition. Unfortunately, global events have disrupted the clinical trial landscape significantly in the past 2 years impacting the hope and lives of millions of people. Although rescue sites are most commonly thought of as an alternative to trials failing for more common reasons like lack of enrollment, Medical Affairs teams should be re-evaluating their overall strategy to make sure that even in the face of uncertainty, there is a path forward for clinical design. Rescue sites can provide that path forward.

In this first of 3 episodes, we will be meeting with an industry expert on Automation within the pharmaceutical industryThe podcast objectives are:   Understand key aspects of Automation to understand the potential opportunities Application of Automation within Medical Affairs – key examples and takeaways Recommendations on how to learn more and how to begin or accelerate your automation journey.

In this second episode, we'll be meeting with Shinya Suda-san, Sr. Vice President and Global Head of Information Systems at Astellas to glean insights on Automation opportunities as it relates to Digital Transformation. The podcast objectives are to:   Understand the potential opportunities that automation has already provided at Astellas Pharma Discuss any future expectations and predictions on how automation can be one of the enablers of a Digital Transformation journey Learn about Digital Transformation best practices and lessons learned  

On today's "Elevate" podcast episode, we're speaking with Eric Peacock, co-founder and CEO of MyHealthTeam about Medical Affairs work with patients in social networks. This episode, sponsored by MyHealthTeam, will address the following questions:What's the big opportunity for Medical Affairs professionals in patient social networks? What have you learned that works in engaging people living with chronic conditions?What role do social networks play in addressing inequities in healthcare?How has the approach to serving patients evolved over the past 10 years?What's the top takeaway from the pandemic that will impact future approach?

In the final of this 3-part series, we will be meeting with Georgios Tramountanis, a member of the MAPS Digital Focus Area Working Group.The podcast objectives are to:  - Examine where we see the potential opportunities for Medical Affairs as it relates to Automation- Discuss what the best places to consider are when developing an Automation journey in Medical Affairs and where to start- Review some predictions on the future of Automation in Medical Affairs.

In this series, brought to your by the MAPS Field Medical Focus Area Working Group, we will be highlighting skills, topics and behaviors that are fundamental to Field Medical success. In this first podcast we will discuss leading through change .

We're sensing a shift within Medical Affairs to make the case for and insist on better measurement, but how do we actually make that a reality? Measuring what really matters is often not straightforward, sometimes expensive and always takes committed up-front thinking and planning. In this first podcast of a 3-part series, we will address this question and discuss: The fundamentals of effective measurement techniques for Medical Affairs.

What do you need to consider when thinking about measurement, and what might this look like in practice? In this second podcast of a 3-part series, we will discuss considerations for measurable engagements in Medical Affairs.

Measuring what really matters is often not straightforward, sometimes expensive, and always takes committed upfront thinking and planning. In this third and final podcast episode in this series, we will discuss measuring and improving the reach and engagement of scientific publications.

Congresses have traditionally been an important opportunity for Medical Affairs to present data while connecting with scientific leaders. But when the world went virtual during the pandemic, there were certainly some things we lost. So, what are the opportunities we gained?

In this episode of the Elevate podcast series, we speak with experts Felix David and Richard Donnelly about the tips and tricks to navigate through peer-review and get sponsored content published. 

With the evolving role of Medical Communications in Medical Affairs, greater partnership and integration in Medical Strategy Planning is key to improve overall Medical Affairs outcomes. Enhanced collaboration between these groups drives strong MedComms execution, leading to increased awareness in the HCP, payer, and regulatory communities. During these podcasts, experienced Medical Strategy and Communications leaders will discuss how you can structure roles and responsibilities, KPIs, and best practices to increase synergy between teams.Learning ObjectivesDefining the roles and responsibilities of Medical Strategy and Medical Communications Communicate best practices in partnering to develop the Medical Strategy and Medical Communications Strategy Discuss ideas for measuring the impact of the Medical Strategy and Medical Communications Strategy

The pharmaceutical and MedTech industries, and specifically Medical Affairs knows how far we are behind big tech in our ability to mine data for meaning. Here MAPS speaks with Mark Michalski, former radiologist and currently Worldwide Head, Healthcare & Life Sciences, Artificial Intelligence and Machine Learning, Amazon Web Services about how we can catch up — from predictive analytics in the .com experience to graph databases and other ways to structure data from the cloud. 

With the evolving role of Medical Communications in Medical Affairs, greater partnership and integration in Medical Strategy Planning is key to improve overall Medical Affairs outcomes. Enhanced collaboration between these groups drives strong MedComms execution, leading to increased awareness in the HCP, payer, and regulatory communities. During these podcasts, experienced Medical Strategy and Communications leaders will discuss how you can structure roles and responsibilities, KPIs, and best practices to increase synergy between teams.Learning ObjectivesDefining key performance indicators Best practices for measuring success of the Medical Strategy and Medical Communications strategyShare experience on insights communication between the two groups to refine strategy

Opening Doors episodes of the MAPS Elevate Podcast Series give Medical Affairs professionals the opportunity to tell the story of how they found their way into the profession and to offer advice to others seeking Medical Affairs positions. Here MAPS co-founder, Kirk Shepard, speaks with Niha Yerneni, Medical Scientific Affairs Manager at Ironwood Pharmaceuticals about joining Medical Affairs and, among other ideas, whether a person with recent postgraduate degree (MD, PhD, PharmD) can be successful in immediately seeking a position in industry or if fellowship or other industry training opportunities are necessary gatekeepers for entry.

This podcast series focuses on how digital is transforming scientific communications.  Season 2 Episode 1 will focus on the struggles and successes of compliance in Medical Communications.  Season 2 Episode 2 will focus on the journal publishing industry, discussing how medical journal publishing is transforming and what changes we might see in the future.  Season 2 Episodes 3 and 4 will focus on open access and how we can make scientific information more accessible and open access more transparent.Description and Objectives:Our podcast objectives are for listeners to better understand:·        Compliance issues and considerations facing publication professionals,·        The transparency complexities encountered by publication professionals·        And concerns related to the use of publications in downstream deliverables

On today's episode of the MAPS "Elevate" podcast, we're discussing the use of Real-World Evidence to understand and possibly intercede in treatment-resistant depression and why is it especially difficult to develop treatments against resistant depression using the traditional structure of R&D-led clinical trials.

In this second podcast in this series, we will discuss delivering constructive feedback.

In this Opening Doors episode of the Medical Affairs Professional Society podcast series, Elevate, we speak with Áine Prendergast, Medical Science Liaison in Oncology with Ipsen. Hear about Áine's path into the profession and learn important advice that can help you find a first MSL position.

This podcast series focuses on how digital is transforming scientific communications.  In this, our second episode this season, we'll be discussing open access in medical publishing from the biopharma perspective.

Patient communities continue to mobilize and play an increasingly important role by influencing many elements of the drug development journey and subsequent patient access and support activities. This input ranges from natural history studies, recruitment in clinical trials, understanding burden, contributing to Health Technology Assessments and co-creating educational resources that enable shared decision making and adherence support. Given Medical Affairs stakeholders have similar reach across drug development and commercialization it is logical that this function plays a central role in an organization's patient-first thinking and strategy. To achieve this, Medical Affairs stakeholders will need to develop thoughtful and impactful strategies that not only build the trust of patient communities but also their internal colleagues.  Here we discuss patient-centricity strategies and actions with Gavin Jones, Global Advisor Rare Disease, OPEN Health, Jenny Ghith, Senior Director, Omnichannel Strategy and Innovations Lead, Pfizer, and Brittany Wolf, Director, Patient Centricity Lead, Pfizer. 

As technology changes the ways we engage with external stakeholders, the skills we need to manage these interactions are changing, as well. Here we speak with Jen Millard, Vice President of Field Medical at IQVIA, about emerging competencies for external engagement. This episode is sponsored by IQVIA. 

Post-approval safety studies have traditionally been cumbersome and expensive, and safety study sites are likely to mirror those used in clinical trials, leading organizations to potentially miss safety signals in populations beyond those that typically participate at trial sites. Here we speak with Stefan C. Weiss, MD, Managing Director, Dermatology at OM1 about a transformation in the way we conduct safety studies — relying on EMR patient data overlain with technology to create a more accurate and equitable view of post-market safety.

Today we're talking about publications impact with Mike Taylor, Head of Data Insights and GRONYA Farrell, Manager Corporate Life Science, Central Europe, both at Digital Science. We'll discuss the questions:Where are we now?Are we looking beyond impact factor? And how to do we make sense of the data and translate "numbers" into "actionable insights". This episode is sponsored by Digital Science, choosing journals and understanding publication impact in the digital age.

In today's episode, we're talking with Joseph Zabinski, PhD, Senior Director, AI & Personalized Medicine at OM1 about Artificial Intelligence — specifically about how AI can accelerate diagnosis and treatment. This episode is sponsored by OM1.

How do you deliver impactful medical education? Hear from industry experts how to design medical education programs successfully for today's healthcare professionals, in our latest podcast episode, sponsored by Wiley.

This series of the Elevate Podcast illuminates the path scientific communication takes from teaching to diagnosis to treating all the way to changing, prolonging, and saving patient lives. External Education of a growing variety of stakeholders in healthcare by the Medical Affairs Division of Pharma and Medical Device industry reflects the critical role Education in Medicine plays in our Age of Information. The podcast features critical discussions with leading educators across healthcare from the various perspectives of pharma / biotech sponsors, program organizers, attendees, and patients with a quest to explore some of the most novel, intriguing formats of Medical Education, following their approaches to learning in our digital age as well as their current gaps or success stories. The goal of the podcast is to make medical education simpler to access, more relevant to apply across healthcare organizations, and more continuous to inspire innovation and quality.This is a first of a series of episodes that examines the podcast as one of the most effective emerging channels and formats of education in medicine. Our host, Tim Mikhelashvili, PharmD, Co-Founder and CEO of Amedea Pharma and Chair of the Mentorship Program at the Medical Affairs Professional Society (MAPS) speaks with Shelby Englert, Vice President of Education at the American Urological Association to learn why podcasts are powerful from a Professional Medical Society's perspective. Shelby explains why its organization started its AUA University podcast, now with 165 episodes and the role it has played in building and growing its community of urologists in the association. She also describes how the AUA University podcast is structured, how it has evolved over time, and shares personal suggestions for elements of education most valuable and relevant to an audience in a podcast, providing specific examples that demonstrate the direct impact of the podcast on patient and physician behaviors as well as health outcomes. Listen to this episode because it not only centers on the ultimate impact of podcasts on the quality of medical education, but also discusses all the “supporting players” and “accessories” to the podcast required such as channels, technology, and timing of podcast communication to make a podcast successful and valuable in healthcare.

On today's episode, we're Speaking with Tim Mikhelashvili, CEO and Co-Founder of Amedea Pharma, and the winners of his Medical Affairs Olympics Competition who dared to come together to share ideas across MA functions.This podcast is sponsored by Amedea Pharma.

When we think about Medical Insights, the first function that comes to mind is Field Medical and capturing/analyzing MSL/HCP interactions in ways that lead to strategic actions. But there are other sources of insights, including the Medical Information function. Many organizations are already capturing and quantifying MedInfo requests to learn more about the types of questions HCPs are asking. Now tools exist to look deeper into this data, allowing MedInfo teams to truly contribute to the generation, analysis of Medical Insights. Learn more in this episode of the MAPS podcast series, Elevate.

MAPS speaks with Tim Mikelhashvili and winners of his Medical Affairs Innovation Olympics about applications that can match patients with clinical trials and provide real-time input to provide context for clinical decisions.

How and why medical publishing is changing and where is it going in the future.The benefits of digital-first development of manuscripts.How enhanced content can improve publication access and resonance.

In this episode of the Elevate podcast series, MAPS speaks with experts from Altmetric about tackling the challenges of an expanding world and understanding who is communicating research by measuring Share of Voice. This episode is sponsored by Altmetric. 

This series of the Elevate Podcast illuminates the path scientific communication takes from teaching to diagnosis to treating all the way to changing, prolonging, and saving patient lives. External Education of a growing variety of stakeholders in healthcare by the Medical Affairs Division of Pharma and Medical Device industry reflects the critical role Education in Medicine plays in our Age of Information. The podcast features critical discussions with leading educators across healthcare from the various perspectives of pharma / biotech sponsors, program organizers, attendees, and patients with a quest to explore some of the most novel, intriguing formats of Medical Education, following their approaches to learning in our digital age as well as their current gaps or success stories. The goal of the podcast is to make medical education simpler to access, more relevant to apply across healthcare organizations, and more continuous to inspire innovation and quality.This second episode in the series discusses the activities of the External Education FAWG and the different learning opportunities that are currently available and coming soon to all MAPS members. Our host, Tim Mikhelashvili, PharmD, Co-Founder and CEO of Amedea Pharma and Chair of the Mentorship Program at the Medical Affairs Professional Society (MAPS) speaks with Sarah Funderburk, SVP Senior Medical Strategy Director with Caudex and Partner Circle member of the External Education FAWG. Sarah discusses some of her learnings from the area of company-led education and her vision for where emerging technologies could take medical education in the future. She addresses the gaps in personalizing education for healthcare consumers and providers based on Salesforce's latest global Connected Health Consumer Report, and reviews the role of programs such as ChatGPT, Tome, and Synesthesia on medical education. Listen to the episode to hear how, when and where you can take advantage of the many exciting activities being offered by the External Education FAWG.

In today's episode of the MAPS "Elevate" podcast, we'll be looking at considerations for Medical Affairs in Rare Disease and Gene Therapy and reviewing the following questions:How do you the see the role of Medical Affairs evolving in the era of advance therapeutics like gene therapy, often investigated for rare disorders? Are there specialized skillsets MA professionals need to be successful in this area? What are three major differences in approach to Med Affairs planning in rare disease, whether or not there is a gene therapy involved? From your experience, what are the biggest hurdles for Med Affairs professionals educating HCPs on gene therapy? It sounds really exciting in concept, but does the reality differ in practice? What advice is there for Med Affairs colleagues wanting to work in either rare disease or gene therapy? Are there specialized roles coming up in this space, different from current roles?

Conference prep requires more than placing publications, securing booth space and scheduling as many KOL meetings as possible. Here we speak with Chris Medieros, Director of Strategic Insights, H1, about how to maximize your organization's presence and impact at congresses, including how to plan strategically across the workflow of KOL interactions.

The role of real-world evidence (RWE) in Medical Affairs has greatly evolved in the last few years. The clinical evidence regarding the potential benefits or risks of a therapy generated from data relating to patient health or the delivery of health care can add value at every stage of a product's lifecycle. RWE can not only help support a product's safe and appropriate use in a post-approval setting, but the data can also inform innovation, trial design, personalized medicine, regulatory filings and optimize decision-making for better patient outcomes. In this episode, we hear from RWE and industry experts on the importance of early alignment of your evidence generation plan and medical strategy and how to integrate RWE into your publication plan.

The goal of all Medical Affairs activities is to improve patient outcomes. That said, until recently, we have measured our progress toward this goal by fairly distant proxy — for example, tracking the number of MSL/HCP interactions as a proxy for providing education that we hope will result in changes in clinical practice. In this episode of the MAPS podcast series, "Elevate", Ariel Katz, co-Founder and CEO of H1, provides a more linear and streamlined vision for how Medical Affairs can impact patient outcomes — and how to measure the results of our actions.

During Covid, many companies developed capabilities to provide eLearning resources, both for internal training and for external education. In this episode, MAPS speaks with Sucharita Kundu, Senior Content Strategist at Wiley and Professor Michael Kirby, currently the Editor of Trends in Urology & Men's Health about best practices for eLearning development and publication. We've transitioned from eLearning provided from a company-centric perspective to courses designed based on deep understanding of an audience's content needs and interaction preferences. This episode teaches listeners to create eLearning resources that are relevant, credible and evidence-based. 

Today's podcast objectives are for listeners to better understand: What innovative content is in the context of Medical Information Expectations of HCPs in accessing innovative contentAnd key learnings in the transition toward the use of more innovative content.

One of the great challenges in Medical Affairs is understanding our opinion and communication networks. Over the last few years, the diversity of stakeholders involved in communicating, advocating, treating and responding to our work has become more complex and dynamic. At the same time, communication routes have proliferated and opened, taking us away from our traditional channels. This wealth of data can be overwhelming. In this podcast, Carlos Areia and Mike Taylor - two data specialists at Digital Science - discuss the ways in which Medical Affairs professionals can use this data to discover your next generation of researchers, those influencers whose voices are heard on Twitter, and how your KOLs are interacting with others online, and which publications they're discussing.

In a post-COVID world, HCPs want to access industry information through self-service content that is available anytime, anywhere — before they engage with representatives from the company. Most companies are aware of this trend. However, most industry organizations are not equipped with the modular content and online platforms needed to deliver this Netflix-like engagement. Here MAPS speaks with Bozidar Jovicevic, MD, MBA, former pharma executive, CEO and cofounder of Evermed, about best practices for gathering content (beyond simply creating it yourself!), and making content accessible in modern, personalized platforms.

Welcome to Part 1 of the MAPS Field Medical Focus Area Working Group's two-part podcast series entitled "Communicating the Value of Field Medical". In this first episode, experts from the FAWG will discuss Field Medical with the following goals in mind:To help the listener communicate the value of Field Medical to internal stakeholdersExplain how to integrate the qualitative and quantitative measures when communicating Field Medical value to internal stakeholdersDiscuss how to build relationships and engage with internal stakeholders

Welcome to Part 2 of the MAPS Field Medical Focus Area Working Group's two-part podcast series entitled "Communicating the Value of Field Medical". In this second episode, experts from the FAWG will discuss Field Medical with the following goals in mind:The participant will be able to learn tips on how to explain the Field Medical value proposition to external stakeholdersLearn how to adapt the proposition when you have just a short time in which to explain itLearn how to adapt the proposition to connect to medical customers more quickly

Partially recorded at the MAPS America's Annual meeting in Nashville, members of the MAPS Digital FAWG interviewed representatives from seven organizations in the MAPS Partner Circle.In this podcast, part 1 of a 3-part series, our experts in the Digital FAWG tackle the question of: “How do you define omnichannel,” with the hopes of helping listeners improve their understanding of omnichannel, the many definitions of omnichannel, and why it is difficult to implement in Medical Affairs.

Partially recorded at the MAPS America's Annual meeting in Nashville, members of the MAPS Digital FAWG interviewed representatives from seven organizations in the MAPS Partner Circle.In this podcast, part 2 of a 3-part series, our experts in the Digital FAWG tackle the question of: “How does a Medical Affairs organization plan for integrating omnichannel activities?"

Partially recorded at the MAPS America's Annual meeting in Nashville, members of the MAPS Digital FAWG interviewed representatives from seven organizations in the MAPS Partner Circle.In this podcast, the FINAL part of this 3-part series, our experts in the Digital FAWG tackle the question of: “How does a Medical Affairs organization measure the success, or value, of omnichannel activities?"

This podcast shares results from the latest Wiley HCP survey, which studies the content habits and preferences of over 900+ HCPs, as well as what they mean for improving engagement with healthcare audiences. Listeners will learn practical tips from the experts on the tactics that are driving impact with today's clinicians. 

Generative AI technologies are allowing Medical Affairs teams to find insights in more and more diverse data in less time and with more robust results. Here MAPS speaks with experts from Virtual Science AI including CEO, Tom Hughes, Chief Customer Officer, Geraldine Reilly, and Chief Technology Officer, Hans Chen about how this word, "Generative," has elevated the promise of AI — and how innovative Medical Affairs teams are leveraging these technologies to provide value for their organizations while driving patient benefit.

At MAPS Global 2023, “omnichannel in Medical Affairs” was a hot topic across numerous sessions. As part of the Field Medical track, Rosie Humphreys, Senior Director at OPEN Health, Donnie Wooten Jr., Global Head of Strategic Medical Content & Omnichannel at Organon and Kelly Lo, Field Medical Excellence, Global and Japan and Asia Pacific at Amgen conducted an interactive workshop, entitled “Optimize your Field Medical Team for the Omnichannel World”. Over 180 attendees, across two sessions, learned how an omnichannel approach is integral to maximizing Field Medical engagement with HCPs. This podcast will discuss the outcomes and insights of that workshop and how Field Medical can build skills and garner support to effectively implement omnichannel strategies.  

When we look at AI, and in particular natural language processing, we think about how we can use these new tools in the medical information space. How do we see the new generative AI models changing what medical information has been doing, especially in the context of chatbots and information dissemination? In this podcast, we interview Matt Lewis, Chief AI Officer at Inizio Medical,  a well-regarded expert in data analytics and augmented intelligence. 

MAPS speaks with Amit Lalwani, omnichannel lead and executive committee member of Medical Affairs Professionals of Australasia and member of the core planning team for the MAPA/MAPS Medical Affairs Summit in Sydney, Australia, November 8-10. 

This podcast reviews new ways of identifying and quantifying opportunities for field medical impact with disease-state analytics. Industry experts from Pfizer and Veeva discuss how longitudinal patient-level data can pave the way for a more patient-centric way of informing and shaping Medical Affairs strategy and operations.

MAPS speaks with Liz de Somer, CEO of Medicines Australia and Sharon Winton, CEO of Lymphoma Australia to explore patient engagement from the perspectives of industry and patient associations. Liz and Sharon are also speaking about this topic at the MAPA/MAPS Medical Affairs Summit in Sydney, AU, Nov 8-10, 2023.

In Medical Affairs, our eyes are open to the vast possibilities of Artificial Intelligence — not only to make our current work more efficient, but to expand our capabilities in areas we never considered possible. Here, MAPS speaks with experts from Pfizer and Putnam Associates about the most exciting current uses of AI and also where we may be headed in the future. Join us for a wild ride through the possibilities of AI. 

In this podcast, we delve into the world of omnichannel strategies in Medical Affairs, where understanding your audience's educational needs and communication preferences is pivotal for delivering relevant and engaging data dissemination. Join us as we explore how to develop effective communications by leveraging various sources of audience understanding, and how to translate information into actionable insights. Discuss what the gold standard for insights could look like and highlight practical suggestions for how to yield robust insights while navigating common challenges often associated with using insights. This podcast provides an overview into the multifaceted process of understanding your audience and explains the complexities and opportunities within the Medical Affairs space to ensure that your communications resonate with your audience, and ultimately, support their educational goals.

In our last podcast episode of this series, we talked with Matt Lewis.  We discussed generative AI, what it is and how it may change and evolve the medical communications environment.  Today, we dive into a really important area that can significantly influence your GenAI results - Prompt Engineering and other areas.

Many of us think about machine learning and AI as a way for an audience to get information: We ask ChatGPT a question and it provides the answer. Here we explore machine learning as a way to get information about an audience — both audience segments/personas and individuals within these groups. We also discuss the limitations and data privacy concerns that distinguish what we "could" know from what we "should" discover. And it turns out machine learning is not just a tool for mining he external environment, but also a way to make sense of a company's internal data to discover hidden experts and resources within the company.

Continuing Medical Education (CME) is transitioning from in-person, day-long seminars to bite-sized, virtual, learn-at-your-own pace courses. Here we talk with experts from Wiley and the world of consulting about new directions in CME — and how to address the continuing need for social learning and perceived authority even as we make information more consumable. 

We know the expectations of our job and we likely know the purpose of our organization. But what is the purpose of your role? What is the golden thread that guides your work? Does it connect to your personal purpose, your organization's purpose or both? Here we speak with Jill Donahue, author of the recently published (free!) book, "A Dose of Inspiration: 100 Purpose Stories from Pharma Leaders" about the individual and organizational benefits of discovering your purpose as an employee in the Life Sciences industry — as well as previewing some of the purpose stories Jill uncovered while writing the book.Links:A Dose of Inspiration: 100 Purpose Stories from Pharma LeadersArticle: Tired of Being Told You Went to the Dark Side?

Modern scientific storytelling is about more than data dissemination — it's about creating meaning for the audience, and as such (as any good bard on the stool of a Medieval tavern knows) it requires truly understanding the audience's motivations and needs. However, scientific storytelling goes further. Our goals are not fiction nor purely entertainment — it's helping HCPs and KOLs make patients lives better. Here we talk about this approach with Murali Gopal, Vice President and Head of Medical Affairs at Phathom Pharmaceuticals and Dave Gulezian, co-Founder and CEO at Alucio. And we ask what is the ONE thing a company must implement in their transformation from the 40-slide deck to modern scientific storytelling. Spoiler alert: They actually agree and it's something that doesn't require budget.

As Medical Affairs professionals, many of us have moved from first careers in academia or healthcare. What did your colleagues say when you told them you were transitioning to pharma? Did they say you were going to the "dark side"? In this episode, we speak with Robert Atkinson, President of the Information Technology and Innovation Foundation and author of the recently published book, Technology Fears and Scapegoats: 40 Myths About Privacy, Jobs, AI, and Today's Innovation Economy. And we explore the origins of negative opinions of the pharmaceutical industry, and whether a for-profit model can support both innovation and the society's best interests. 

When Medical Affairs was a support function, it was enough to count the actions we performed to aid the missions of our collaborators in Commercial and R&D. Now that Medical is a strategic partner alongside these other functions, we must measure and message our OWN mission. But how can we draw a line of causality or at least contribution from actions to impact? Here we speak with Diana Morgenstern, MD, Fellow of the American College of Physicians, member of the MAPS EvGen Domain Team, and Executive Strategist in the IQVIA US Medical Affairs Center of Excellence, and Javier Lopez-Molina, MBA, Senior Director of in the US Medical Affairs Center of Excellence, IQVIA about exactly this challenge. And we ask a very important question: now that we appreciate the need to demonstrate impact and technologies exist that allow us to measure impact...what's holding us back?

In this podcast, we discuss a data-driven approach for optimizing congress planning and execution. MAPS speaks with experts from United Therapeutics and Veeva for tips on finding the right events, effectively engaging the right experts, and enabling medical teams to do more with less.

Is there a correlation between a higher journal impact factor and increased reach and engagement? The answer has always been, "Of course!" But now with companies driving their own engagement, and alternatives to the journals becoming more mainstream and accepted everyday, the answer is more nuanced. Join our expert guests from Digital Science to discuss the NEW metrics of journal publication.

A PubMed search on the day this was written finds 36,735 new publications in the last 24 hours. Adding the word “oncology” narrows the number to 4,334. Substituting “lung cancer” for “oncology” results in 534 articles. How many of these do you think your HCPs and KOLs will be able to read before the next batch of publications comes out tomorrow? This is to say that publishing a scientific study or article can feel like squeezing an eyedropper into the ocean and it is the job of the publication's team to ensure this drop-in-the-ocean has impact — especially when publishing a study with the potential to change clinical practice. Here we learn practical tips straight from the source – namely, experts at Wiley. How can you translate peer-reviewed publications to clinical impact? How can licensing extend (or perhaps restrict…) the reach of published research? How can publications be leveraged as the hub of an omnichannel approach? Listen to learn more.

When you think about innovation in Medical Affairs, perhaps the first things that come to mind are GenAI or maybe new approaches to KOL network mapping. But what about innovation in the ways we approach the profession itself? What about innovation in how we continue to evolve our own skills and understanding of our roles in industry and beyond? Here we speak with Tim Mikelhashvili, CEO of Amedea Pharma about innovation in Medical Affairs leadership -- and innovation for leaders. We also look forward to Tim's 2024 Medical Affairs Innovation Olympics. Enter your innovative idea now or register to attend!

Getting the most impact from a publication requires being able to define who the audience is and how to reach them, across both journals and online channels, especially in complex/niche cases. In this podcast, we'll discuss the benefits of taking an analytical approach.

Here we speak with Kate Davies, Nurse Educator at London South Bank University and expert in clinical endocrine research focusing on genetics in short stature, clinical trials, and differences in sex development. Throughout Kate's research and work as a pediatric nurse, she has developed expertise in engaging with patient communities, often providing trusted information to these groups and also learning about the real-world experiences of patients in the context of treatment and clinical trials. Here is what a patient advocate wants Medical Affairs to know about patient engagement -- and join us at our LinkedIn discussion on this topic to ask your own questions about engaging with patients. 

As the sources of data and technologies needed to make sense of data expand, opportunities exist for further integrating Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) alongside traditional approaches when planning data generation activities to support new product registration, access, and use. Here we speak with experts from Lumanity about the Integrated Evidence Generation Planning (IEGP) process and how to overcome the barriers to success. 

Recorded at the MAPS 2024 Annual Meeting in Puerto Rico following a workshop on modular content in which all of today's speakers were faculty. Lead by the Digital FAWG's Jennifer Riggins and Steve Casey, today's panelists touch on the topic of modular content in the following areas: Inspiration and ImpactContent Compliance & ApprovalMSL UtilizationTraining & EvolutionThe Technology StackThe Future of Modular Content For more information on Modular Content, explore the MAPS White Paper: “Modular Content in Medical Affairs: The Foundation of Omnichannel Engagement” HERE: https://medicalaffairs.org/modular-content-omnichannel-engagement/

 This session takes a closer look at one of the key challenges associated with integrated evidence generation planning that was identified in our first installment. Experts share insights and practical advice on ways to identify and overcome barriers to aligning multiple functions in the development and implementation of integrated evidence generation plans to minimize risk and optimize value, accounting for medical affairs, patient, regulatory and commercial perspectives. 

This podcast speaks with experts from Altmetric to delve into different methods for extracting insights to comprehend the influence of a publication on key metrics such as citations, public engagement, social impact, and internal metrics. The aim is to speed up the evaluation process to determine if publications are effectively reaching and educating the appropriate HCPs to influence their clinical decisions.

Overcoming regional disparities to ensure successful IEGP development and implementation requires effective strategies for cross-functional collaboration across diverse regions and departments. In this podcast, experts explore the many challenges associated with the operationalization of global Integrated Evidence Generation Planning (IEGP) at local levels.

In this podcast, we explore how digitally active HCPs and emerging experts can amplify the impact of scientific data presented at congresses to drive successful drug launches. Industry experts from Pfizer and Veeva discuss strategies for engaging these key influencers to optimize launch success.

In this podcast episode, we share insights from the Wiley annual healthcare professionals survey and interviews on the sources of information they seek and trust. You will learn about how their content needs and preference are evolving and the factors driving their information choices and educational needs. A must listen for those looking to advance their HCP engagement with practical tips to enhance your medical education strategy. 

Believe it or not, the field of Kardashian studies can inform the ways Medical Affair professionals identify and understand influencers and influence in the space of science communications. Here we talk with Mike Taylor, Head of Data Insights at Altmetric, and Carlos Areia, Senior Data Scientist at Altmetric about making sense of what is otherwise certainly nonsense. 

The Times Higher Education recently reported that Bluesky has overtaken X in hosting posts related to new academic research. And yet many Medical Affairs teams aren't equipped to maximize the potential of this emerging resources. Here we speak with Mike Taylor, Head of Data Insights, at Altmetric, and Carlos Areia, Senior Data Scientist at Altmetric about the uses of Bluesky in comparison with exiting social media platforms, and how Medical Affairs can leverage this resource for insights, KOL identification/mapping, data dissemination and more. 

Expedited publications are essential for rapidly disseminating research findings and accelerating drug approval processes, particularly during public health emergencies. This approach encompasses efficient manuscript development, expedited reviews, and prioritized submissions to scientific journals, ultimately ensuring that critical data swiftly reaches the healthcare community. The urgency for timely information is underscored by examples such as COVID-19, where rapid dissemination played a significant role in updating treatment protocols and informing vaccine practices. However, the podcast also addresses significant challenges faced, including regulatory hurdles, resource constraints, and the risk of compromising research integrity due to pressures for rapid output. Stakeholders such as pharmaceutical companies, regulatory agencies, healthcare providers, and patients can benefit from expedited publications, yet they must navigate the fine balance between speed and quality. By exploring methodologies for successful expedited publishing, including pre-planning, stakeholder engagement, and strategic communication, this podcast highlights the importance of a robust framework for overcoming hurdles and fostering advancements in pharmaceutical research and public health.